BackLuye Pharma Group Overview

Luye Pharma Group Total Assets

Latest total assets for LYPHF: $35B.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$34.87B
↑ 8.87% YoYΔ $2.84B vs prior year quarter

Peer trimmed avg / median

Loading

Luye Pharma Group Total Assets History

Loading

Luye Pharma Group vs. peers: Total Assets Comparison

Loading

Luye Pharma Group Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Luye Pharma Group (LYPHF) FAQ

As of the most recent data (June 2026), LYPHF shows a total assets of $35B. That compares with $32B in the prior-year period — up 8.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, LYPHF's total assets is now $35B (was $32B) — a 8.9% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Luye Pharma Group is outperforming or lagging.

Tracking LYPHF's total assets over time shows whether Luye Pharma Group is scaling, shrinking, or reshaping that part of the business. The current reading is $35B That compares with $32B in the prior-year period — up 8.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total assets page, Stockcircle has Luye Pharma Group's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total assets (currently $35B) with ownership activity and broader fundamentals.